trial

Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)

NCTId NCT07586150
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 140 (estimated)
Sponsored by Ludwig-Maximilians - University of Munich
Primary completion 2030-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
140 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2028-10
Primary completion
2030-07
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Semaglutide (SEMA)Exercise moduleAnti-inflammatory diet moduleSleep intervention moduleSocial prescribing moduleClosed-loop transcranial alternating current stimulation (CL-tACS)Structured lifestyle psychoeducation

Sponsors

Ludwig-Maximilians - University of MunichLead Sponsor

Sites

5 total
Vienna, AustriaMannheim, GermanyMünchen, GermanyGroningen, NetherlandsUtrecht, Netherlands

Facts & assertions

4 sourced
Enrollment
140
Phase
NA
Primary Completion Date
2030-07
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Semaglutide (SEMA)
drug
Exercise module
drug
Anti-inflammatory diet module
drug
Sleep intervention module
drug
Social prescribing module
drug
Closed-loop transcranial alternating current stimulation (CL-tACS)
drug
Structured lifestyle psychoeducation
drug
lead_sponsor
Ludwig-Maximilians - University of Munich
company
indication
Bipolar Disorder
indication
Severe Mental Illness
indication
Depression / Major Depressive Disorder
indication